-
1
-
-
0033019865
-
Surgical therapy for ulcerative colitis and Crohn's disease
-
Becker JM. Surgical therapy for ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1999;28:371-90.
-
(1999)
Gastroenterol Clin North Am
, vol.28
, pp. 371-390
-
-
Becker, J.M.1
-
2
-
-
0025013473
-
Predictability of the postoperative course of Crohn's disease
-
Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99:956-63. (Pubitemid 20338451)
-
(1990)
Gastroenterology
, vol.99
, Issue.4
, pp. 956-963
-
-
Rutgeerts, P.1
Geboes, K.2
Vantrappen, G.3
Beyls, J.4
Kerremans, R.5
Hiele, M.6
-
3
-
-
0036301471
-
Inflammatory bowel disease: Medical therapy of specific clinical presentations
-
DOI 10.1016/S0889-8553(01)00012-7, PII S0889855301000127
-
Banerjee S, Peppercorn MA. Inflammatory bowel disease: medical therapy of specific clinical presentations. Gastroenterol Clin North Am 2002;31:185-202. (Pubitemid 34733040)
-
(2002)
Gastroenterology Clinics of North America
, vol.31
, Issue.1
, pp. 185-202
-
-
Banerjee, S.1
Peppercorn, M.A.2
-
5
-
-
0028900762
-
Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease
-
Italian Cooperative Study Group
-
Brignola C, Cottone M, Pera A, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Italian Cooperative Study Group. Gastroenterology 1995;108:345-9.
-
(1995)
Gastroenterology
, vol.108
, pp. 345-349
-
-
Brignola, C.1
Cottone, M.2
Pera, A.3
-
6
-
-
0028264154
-
Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease
-
Gruppo Italiano per lo Studio del Colon e del Retto (GISC)
-
Caprilli R, Andreoli A, Capurso L, et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther 1994;8:35-43.
-
(1994)
Aliment Pharmacol Ther
, vol.8
, pp. 35-43
-
-
Caprilli, R.1
Andreoli, A.2
Capurso, L.3
-
7
-
-
9244235034
-
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease
-
Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID)
-
Florent C, Cortot A, Quandale P, et al. Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol 1996;8:229-33.
-
(1996)
Eur J Gastroenterol Hepatol
, vol.8
, pp. 229-233
-
-
Florent, C.1
Cortot, A.2
Quandale, P.3
-
8
-
-
0033965199
-
Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI
-
Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI. Gastroenterology 2000;118:264-73.
-
(2000)
Gastroenterology
, vol.118
, pp. 264-273
-
-
Lochs, H.1
Mayer, M.2
Fleig, W.E.3
-
9
-
-
0029128340
-
Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease
-
Mcleod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995;109:404-13.
-
(1995)
Gastroenterology
, vol.109
, pp. 404-413
-
-
Mcleod, R.S.1
Wolff, B.G.2
Steinhart, A.H.3
-
10
-
-
0041395773
-
A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease
-
Sutherland LR, Martin F, Bailey RJ, et al. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. Gastroenterology 1997;112:1069-77.
-
(1997)
Gastroenterology
, vol.112
, pp. 1069-1077
-
-
Sutherland, L.R.1
Martin, F.2
Bailey, R.J.3
-
11
-
-
0030775667
-
Mesalamine in the maintenance treatment of Crohn's disease: A meta-analysis adjusted for confounding variables
-
Camma C, Giunta M, Rosselli M, et al. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology 1997;113:1465-73.
-
(1997)
Gastroenterology
, vol.113
, pp. 1465-1473
-
-
Camma, C.1
Giunta, M.2
Rosselli, M.3
-
12
-
-
33144459948
-
European evidence based consensus on the diagnosis and management of Crohn's disease: Current management
-
Travis SPL, Stange EF, Lemann M, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006;55(Suppl 1):i16-35.
-
(2006)
Gut
, vol.55
, Issue.SUPPL. 1
-
-
Travis, S.P.L.1
Stange, E.F.2
Lemann, M.3
-
13
-
-
36349024564
-
Azathioprine for prevention of postoperative recurrence in Crohn's disease
-
Abdelli MN, Ben AH, Houissa F, et al. [Azathioprine for prevention of postoperative recurrence in Crohn's disease]. Tunis Med 2007;85:569-72.
-
(2007)
Tunis Med
, vol.85
, pp. 569-572
-
-
Abdelli, M.N.1
Ben, A.H.2
Houissa, F.3
-
14
-
-
33749037153
-
Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease
-
Myrelid P, Svarm S, Andersson P, et al. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease. Scand J Gastroenterol 2006;41:1190-5.
-
(2006)
Scand J Gastroenterol
, vol.41
, pp. 1190-1195
-
-
Myrelid, P.1
Svarm, S.2
Andersson, P.3
-
15
-
-
53249097726
-
Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: A controlled randomized trial
-
D'Haens GR, Vermeire S, Van Assche G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology 2008;135:1123-9.
-
(2008)
Gastroenterology
, vol.135
, pp. 1123-1129
-
-
D'Haens, G.R.1
Vermeire, S.2
Van Assche, G.3
-
16
-
-
4444353986
-
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trial
-
Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004;127:723-9.
-
(2004)
Gastroenterology
, vol.127
, pp. 723-729
-
-
Hanauer, S.B.1
Korelitz, B.I.2
Rutgeerts, P.3
-
17
-
-
4444366271
-
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease
-
Ardizzone S, Maconi G, Sampietro GM, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004;127:730-40.
-
(2004)
Gastroenterology
, vol.127
, pp. 730-740
-
-
Ardizzone, S.1
Maconi, G.2
Sampietro, G.M.3
-
18
-
-
73949083566
-
Endscopy and MR enteroclysis: Equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection
-
Koilakou S, Sailer J, Peloschek P, et al. Endscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection. Inflamm Bowel Dis 2010;16:198-203.
-
(2010)
Inflamm Bowel Dis
, vol.16
, pp. 198-203
-
-
Koilakou, S.1
Sailer, J.2
Peloschek, P.3
-
19
-
-
0017227303
-
Development of a Crohn's disease activity index
-
National Cooperative Crohn's Disease Study
-
Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
-
(1976)
Gastroenterology
, vol.70
, pp. 439-444
-
-
Best, W.R.1
Becktel, J.M.2
Singleton, J.W.3
-
20
-
-
0028047268
-
Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease
-
Canadian Crohn's Relapse Prevention Trial Study Group
-
Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology 1994;106:287-96.
-
(1994)
Gastroenterology
, vol.106
, pp. 287-296
-
-
Irvine, E.J.1
Feagan, B.2
Rochon, J.3
-
21
-
-
33847153405
-
Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine
-
Dilger K, Schaeffeler E, Lukas M, et al. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine. Ther Drug Monit 2007;29:1-5.
-
(2007)
Ther Drug Monit
, vol.29
, pp. 1-5
-
-
Dilger, K.1
Schaeffeler, E.2
Lukas, M.3
-
22
-
-
3242762099
-
Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants
-
Schaeffeler E, Fischer C, Brockmeier D, et al. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 2004;14:407-17.
-
(2004)
Pharmacogenetics
, vol.14
, pp. 407-417
-
-
Schaeffeler, E.1
Fischer, C.2
Brockmeier, D.3
-
23
-
-
0024356033
-
Development and validation of an endoscopic index of the severity for Crohn's disease: A prospective multicentre study
-
Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)
-
Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989;30:983-9.
-
(1989)
Gut
, vol.30
, pp. 983-989
-
-
Mary, J.Y.1
Modigliani, R.2
-
24
-
-
70449596780
-
SONIC: A randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy
-
P087
-
Colombel JF, Rutgeerts P, Reinisch W, et al. SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy. J Crohn's and Colitis 2009;3:S45 (P087).
-
(2009)
J Crohn's and Colitis
, vol.3
-
-
Colombel, J.F.1
Rutgeerts, P.2
Reinisch, W.3
-
25
-
-
33749189358
-
Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease
-
AZT-1 Study Group
-
Herfarth H, Tjaden C, Lukas M, et al. AZT-1 Study Group. Adverse events in clinical trials with azathioprine and mesalamine for prevention of postoperative recurrence of Crohn's disease. Gut 2006;55:1525-6.
-
(2006)
Gut
, vol.55
, pp. 1525-1526
-
-
Herfarth, H.1
Tjaden, C.2
Lukas, M.3
-
26
-
-
68349137946
-
Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: A meta-analysis
-
Peyrin-Biroulet L, Deltenre P, Ardizzone S, et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis. Am J Gastroenterol 2009;104:2089-96.
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 2089-2096
-
-
Peyrin-Biroulet, L.1
Deltenre, P.2
Ardizzone, S.3
-
27
-
-
7044268960
-
Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases
-
Weersma RK, Peters FTM, Oostenbrug LE, et al. Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases. Aliment Pharmacol Ther 2004;20:843-50.
-
(2004)
Aliment Pharmacol Ther
, vol.20
, pp. 843-850
-
-
Weersma, R.K.1
Peters, F.T.M.2
Oostenbrug, L.E.3
-
28
-
-
77953692159
-
Anzathioprine
-
Thomson Reuters (Healthcare) Inc. Greenwood Village, Colorado, USA: Thomson Reuters (Healthcare)
-
Thomson Reuters (Healthcare) Inc. Anzathioprine. In: DRUGDEX® System [database on CD-ROM]. Greenwood Village, Colorado, USA: Thomson Reuters (Healthcare), 2010:143.
-
(2010)
DRUGDEX® System [Database on CD-ROM]
, pp. 143
-
-
-
29
-
-
0030048791
-
Thiopurine methyltransferase pharmacogenetics: Human gene cloning and characterization of a common polymorphism
-
Szumlanski C, Otterness D, Her C, et al. Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism. DNA Cell Biol 1996;15:17-30.
-
(1996)
DNA Cell Biol
, vol.15
, pp. 17-30
-
-
Szumlanski, C.1
Otterness, D.2
Her, C.3
-
30
-
-
0029919807
-
Thiopurine S-methyltransferase deficiency: Two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians
-
Tai H-L, Krynetski EY, Yates CR, et al. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet 1996;58:694-702.
-
(1996)
Am J Hum Genet
, vol.58
, pp. 694-702
-
-
Tai, H.-L.1
Krynetski, E.Y.2
Yates, C.R.3
-
31
-
-
0034067784
-
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
-
Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000;118:705-13. (Pubitemid 30171620)
-
(2000)
Gastroenterology
, vol.118
, Issue.4
, pp. 705-713
-
-
Dubinsky, M.C.1
Lamothe, S.2
Yang, H.Y.3
Targan, S.R.4
Sinnett, D.5
Theoret, Y.6
Seidman, E.G.7
-
32
-
-
1842788679
-
Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity
-
Nygaard U, Toft N, Schmiegelow K. Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity. Clin Pharmacol Ther 2004;75:274-81.
-
(2004)
Clin Pharmacol Ther
, vol.75
, pp. 274-281
-
-
Nygaard, U.1
Toft, N.2
Schmiegelow, K.3
-
33
-
-
33947287144
-
Thiopurine treatment in inflammatory bowel disease: Clinical pharmacology and implication of pharmacogenetically guided dosing
-
Teml A, Schaeffeler E, Herrlinger KR, et al. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. Clin Pharm 2007;46:187-208.
-
(2007)
Clin Pharm
, vol.46
, pp. 187-208
-
-
Teml, A.1
Schaeffeler, E.2
Herrlinger, K.R.3
-
34
-
-
48549088791
-
Transporter-mediated protection against thiopurine-induced hematopoietic toxicity
-
Krishnamurthy P, Schwab M, Takenaka K, et al. Transporter-mediated protection against thiopurine-induced hematopoietic toxicity. Cancer Res 2008;68:4983-9.
-
(2008)
Cancer Res
, vol.68
, pp. 4983-4989
-
-
Krishnamurthy, P.1
Schwab, M.2
Takenaka, K.3
-
35
-
-
58449117037
-
Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia
-
Stocco G, Cheok MH, Crews KR, et al. Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia. Clin Pharmacol Ther 2009;85:164-72.
-
(2009)
Clin Pharmacol Ther
, vol.85
, pp. 164-172
-
-
Stocco, G.1
Cheok, M.H.2
Crews, K.R.3
-
36
-
-
31144446293
-
Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression
-
Zelinkova Z, Derijks LJ, Stokkers PC, et al. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression. Clin Gastroenterol Hepatol 2006;4:44-9.
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 44-49
-
-
Zelinkova, Z.1
Derijks, L.J.2
Stokkers, P.C.3
-
37
-
-
65449156896
-
Leukopenia due to parvovirus B19 in a Crohn's disease patient using azathioprine
-
van Asseldonk DP, Kanis BM, de Boer NK, et al. Leukopenia due to parvovirus B19 in a Crohn's disease patient using azathioprine. Digestion 2009;79:211-14.
-
(2009)
Digestion
, vol.79
, pp. 211-214
-
-
Van Asseldonk, D.P.1
Kanis, B.M.2
De Boer, N.K.3
|